Polypharmacy in schizophrenia: a fuzzy concept

J Clin Psychiatry. 2003 Sep;64(9):1132; author reply 1132-3. doi: 10.4088/jcp.v64n0921d.
No abstract available

Publication types

  • Comment
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / economics
  • Cost-Benefit Analysis
  • Drug Costs / statistics & numerical data
  • Drug Therapy, Combination
  • Evidence-Based Medicine
  • Female
  • Humans
  • Male
  • Middle Aged
  • Schizophrenia / drug therapy*
  • Schizophrenia / economics
  • Schizophrenic Psychology*

Substances

  • Antipsychotic Agents